Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S416 - S416
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S416 - S416
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3517 - 3524
Purpose Brivanib is a dual inhibitor of vascular-endothelial growth factor and fibroblast growth factor receptors that are implicated in the pathogenesis of...
EXPRESSIONS | MODIFIED RECIST | ALANINATE | MODELS | ONCOLOGY | RESISTANCE | DUAL INHIBITOR | FIBROBLAST-GROWTH-FACTOR | FACTOR RECEPTOR-2 | TUMORS | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Alanine - therapeutic use | Prognosis | Follow-Up Studies | Triazines - therapeutic use | Humans | Middle Aged | Male | Liver Neoplasms - mortality | Young Adult | Alanine - analogs & derivatives | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Double-Blind Method | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Survival Rate | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging
EXPRESSIONS | MODIFIED RECIST | ALANINATE | MODELS | ONCOLOGY | RESISTANCE | DUAL INHIBITOR | FIBROBLAST-GROWTH-FACTOR | FACTOR RECEPTOR-2 | TUMORS | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Alanine - therapeutic use | Prognosis | Follow-Up Studies | Triazines - therapeutic use | Humans | Middle Aged | Male | Liver Neoplasms - mortality | Young Adult | Alanine - analogs & derivatives | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Double-Blind Method | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Survival Rate | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0145953
BACKGROUND: The treatment of hepatitis C (HCV) infections has significantly changed in the past few years due to the introduction of direct-acting antiviral...
Meta-Analysis | Humans | Fatigue | Genotype | Treatment Outcome | Antiviral Agents | Review | Viral Load | Journal Article | Time Factors | Publication Bias | Drug Therapy, Combination | Hepatitis C | Odds Ratio | Hepacivirus | GENETIC-VARIATION | PLUS RIBAVIRIN | CHRONIC HCV | MULTIDISCIPLINARY SCIENCES | PEGYLATED INTERFERON | DOUBLE-BLIND | FIXED-DOSE COMBINATION | OPEN-LABEL | INFECTION | INTERFERON-ALPHA 2A | PHASE-2 TRIAL | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Fatigue - etiology | Hepacivirus - genetics | Antiviral Agents - administration & dosage | Antiviral Agents - adverse effects | Hepatitis C - virology | Ritonavir | Bias | Clinical trials | Systematic review | Infections | Ribavirin | Incidence | Hepatitis | Genotype & phenotype | Drug dosages | Public health | Genotypes | Antiviral agents | Effectiveness | Anemia | Meta-analysis | Medicine | Studies | Side effects | Hospitals | Reviews | Interferon | Hepatitis C virus
Meta-Analysis | Humans | Fatigue | Genotype | Treatment Outcome | Antiviral Agents | Review | Viral Load | Journal Article | Time Factors | Publication Bias | Drug Therapy, Combination | Hepatitis C | Odds Ratio | Hepacivirus | GENETIC-VARIATION | PLUS RIBAVIRIN | CHRONIC HCV | MULTIDISCIPLINARY SCIENCES | PEGYLATED INTERFERON | DOUBLE-BLIND | FIXED-DOSE COMBINATION | OPEN-LABEL | INFECTION | INTERFERON-ALPHA 2A | PHASE-2 TRIAL | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Fatigue - etiology | Hepacivirus - genetics | Antiviral Agents - administration & dosage | Antiviral Agents - adverse effects | Hepatitis C - virology | Ritonavir | Bias | Clinical trials | Systematic review | Infections | Ribavirin | Incidence | Hepatitis | Genotype & phenotype | Drug dosages | Public health | Genotypes | Antiviral agents | Effectiveness | Anemia | Meta-analysis | Medicine | Studies | Side effects | Hospitals | Reviews | Interferon | Hepatitis C virus
Journal Article
5.
Full Text
Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome
世界胃肠药理与治疗学杂志:英文版(电子版), ISSN 2150-5349, 2015, Volume 6, Issue 3, pp. 28 - 31
Spontaneous bacterial peritonitis(SBP),refractory ascites,hepatorenal syndrome(HRS),hyponatremia and hepatic encephalopathy are complicationswhich frequently...
kidney | Cirrhosis | syndrome | Acute | Albumin | injury | Hepatorenal | Vasoconstrictor | Hepatorenal syndrome | Acute kidney injury
kidney | Cirrhosis | syndrome | Acute | Albumin | injury | Hepatorenal | Vasoconstrictor | Hepatorenal syndrome | Acute kidney injury
Journal Article
BMC GASTROENTEROLOGY, ISSN 1471-230X, 08/2019, Volume 19, Issue 1, pp. 150 - 17
Background Alcoholic liver disease (ALD) is the leading cause of liver transplantation (LT). The magnitude and risk factors of post-LT alcohol relapse are not...
SURVIVAL | Relapse | RISK-FACTORS | Recidivism | Alcohol | PRETRANSPLANT ABSTINENCE | Psychiatric comorbidity | HEPATITIS | CARBOHYDRATE-DEFICIENT TRANSFERRIN | CIRRHOSIS | TERM-FOLLOW-UP | RETROSPECTIVE ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | HARMFUL ALCOHOL | Liver transplantation | Comorbidity | Analysis | Liver | Transplantation | Drinking of alcoholic beverages | Liver cirrhosis | Risk factors | Diseases | Liver diseases | Statistical analysis | Transplants & implants | Syngeneic grafts | Systematic review | Epidemiology | Search strategies | Alcohol use | Meta-analysis | Medicine | Studies | Hepatitis | Hospitals | Allografts | Smoking
SURVIVAL | Relapse | RISK-FACTORS | Recidivism | Alcohol | PRETRANSPLANT ABSTINENCE | Psychiatric comorbidity | HEPATITIS | CARBOHYDRATE-DEFICIENT TRANSFERRIN | CIRRHOSIS | TERM-FOLLOW-UP | RETROSPECTIVE ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | HARMFUL ALCOHOL | Liver transplantation | Comorbidity | Analysis | Liver | Transplantation | Drinking of alcoholic beverages | Liver cirrhosis | Risk factors | Diseases | Liver diseases | Statistical analysis | Transplants & implants | Syngeneic grafts | Systematic review | Epidemiology | Search strategies | Alcohol use | Meta-analysis | Medicine | Studies | Hepatitis | Hospitals | Allografts | Smoking
Journal Article
BMC Complementary and Alternative Medicine, ISSN 1472-6882, 09/2015, Volume 15, Issue 1, p. 334
Background: Hepatitis is a common adverse effect of antituberculosis drugs. Silymarin prevented drug-induced hepatoxicity in animals with anti-oxidative...
Drug-induced liver injury | Tuberculosis | Silymarin | Antioxidant | Hepatotoxicity | INDUCED HEPATIC-INJURY | OXIDATIVE STRESS | RISK-FACTORS | TREATMENT-INDUCED HEPATOTOXICITY | RATS | N-ACETYLCYSTEINE | MODEL | DISEASES | INTEGRATIVE & COMPLEMENTARY MEDICINE | PYRAZINAMIDE | Malondialdehyde - metabolism | Silymarin - therapeutic use | Antitubercular Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Male | Protective Agents - therapeutic use | Young Adult | Animals | Adolescent | Chemical and Drug Induced Liver Injury - drug therapy | Aged, 80 and over | Adult | Female | Aged | Superoxide Dismutase - metabolism | Prevention | Research | Comparative analysis
Drug-induced liver injury | Tuberculosis | Silymarin | Antioxidant | Hepatotoxicity | INDUCED HEPATIC-INJURY | OXIDATIVE STRESS | RISK-FACTORS | TREATMENT-INDUCED HEPATOTOXICITY | RATS | N-ACETYLCYSTEINE | MODEL | DISEASES | INTEGRATIVE & COMPLEMENTARY MEDICINE | PYRAZINAMIDE | Malondialdehyde - metabolism | Silymarin - therapeutic use | Antitubercular Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Male | Protective Agents - therapeutic use | Young Adult | Animals | Adolescent | Chemical and Drug Induced Liver Injury - drug therapy | Aged, 80 and over | Adult | Female | Aged | Superoxide Dismutase - metabolism | Prevention | Research | Comparative analysis
Journal Article
BIOMED RESEARCH INTERNATIONAL, ISSN 2314-6133, 08/2019, Volume 2019, pp. 9047324 - 9
Polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver (NAFLD) share similar clinical presentations including obesity, insulin resistance (IR), and...
FIBROSIS | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | VISCERAL FAT | RISK-FACTOR | STEATOSIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | INSULIN-RESISTANCE | CONTROLLED ATTENUATION PARAMETER | STEATOHEPATITIS | ASSOCIATION | NONINVASIVE ASSESSMENT | Type 2 diabetes | Women | Obesity | Medical research | Fatty liver | Ultrasound imaging | Stein-Leventhal syndrome | Medicine, Experimental | Insulin resistance | Diagnosis | Comparative analysis | Health aspects | Laboratories | Liver | Correlation coefficients | Thyroid gland | Family medical history | Alcohol use | Confidence intervals | Ultrasonic imaging | Gastroenterology | Ultrasonography | Attenuation | Ultrasound | Correlation coefficient | Hypertension | Polycystic ovary syndrome | Liver diseases | Metabolism | Insulin | Steatosis | Androgens | Lipoproteins | Womens health | Infertility | Fibrosis | Alcoholic beverages | Diagnostic systems
FIBROSIS | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | VISCERAL FAT | RISK-FACTOR | STEATOSIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | INSULIN-RESISTANCE | CONTROLLED ATTENUATION PARAMETER | STEATOHEPATITIS | ASSOCIATION | NONINVASIVE ASSESSMENT | Type 2 diabetes | Women | Obesity | Medical research | Fatty liver | Ultrasound imaging | Stein-Leventhal syndrome | Medicine, Experimental | Insulin resistance | Diagnosis | Comparative analysis | Health aspects | Laboratories | Liver | Correlation coefficients | Thyroid gland | Family medical history | Alcohol use | Confidence intervals | Ultrasonic imaging | Gastroenterology | Ultrasonography | Attenuation | Ultrasound | Correlation coefficient | Hypertension | Polycystic ovary syndrome | Liver diseases | Metabolism | Insulin | Steatosis | Androgens | Lipoproteins | Womens health | Infertility | Fibrosis | Alcoholic beverages | Diagnostic systems
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 04/2017, Volume 17, Issue 1, pp. 50 - 7
Background: Controlled attenuation parameter (CAP) and liver stiffness (LS) measured by transient elastography (TE, Fibroscan (R)) have been used for steatosis...
Controlled attenuation parameter | Liver stiffness | Transient elastography | Fibrosis | Meal | Steatosis | DIAGNOSIS | VIRUS | CHRONIC HEPATITIS-C | BIOPSY | VALIDATION | CAP | DISEASE | FATTY LIVER | GASTROENTEROLOGY & HEPATOLOGY | Severity of Illness Index | Liver - pathology | Fasting | Fatty Liver - pathology | Humans | Middle Aged | Male | Fatty Liver - diagnostic imaging | Liver Cirrhosis - diagnostic imaging | Biopsy | Liver - diagnostic imaging | Postprandial Period | Liver Cirrhosis - pathology | Adult | Female | Elasticity Imaging Techniques | Liver diseases | Statistical analysis | Liver | Patients | Body mass index | Hepatitis | Ultrasonic imaging | Hepatology | Multilevel | Attenuation | Stiffness | Kidney diseases | Meals | Food
Controlled attenuation parameter | Liver stiffness | Transient elastography | Fibrosis | Meal | Steatosis | DIAGNOSIS | VIRUS | CHRONIC HEPATITIS-C | BIOPSY | VALIDATION | CAP | DISEASE | FATTY LIVER | GASTROENTEROLOGY & HEPATOLOGY | Severity of Illness Index | Liver - pathology | Fasting | Fatty Liver - pathology | Humans | Middle Aged | Male | Fatty Liver - diagnostic imaging | Liver Cirrhosis - diagnostic imaging | Biopsy | Liver - diagnostic imaging | Postprandial Period | Liver Cirrhosis - pathology | Adult | Female | Elasticity Imaging Techniques | Liver diseases | Statistical analysis | Liver | Patients | Body mass index | Hepatitis | Ultrasonic imaging | Hepatology | Multilevel | Attenuation | Stiffness | Kidney diseases | Meals | Food
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 4, pp. S336 - S336
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2009, Volume 15, Issue 24, pp. 3032 - 3037
AIM: To evaluate the effectiveness of simethicone in enhancing visibility and efficacy during colonoscopy. METHODS: A prospective, double-blind, randomized,...
结肠镜 | 肠道 | 满意度 | 质量 | 磷酸钠 | 瓦斯 | 能见度 | 检查 | Bowel preparation | Colonoscopy | Simethicone | MULTICENTER | EFFICACY | PROSPECTIVE TRIAL | RANDOMIZED-TRIAL | ORAL CONTRAST AGENT | VISIBILITY | COATED CELLULOSE | COLONIC LAVAGE | ELECTROLYTE LAVAGE SOLUTION | GASTROENTEROLOGY & HEPATOLOGY | CAPSULE ENDOSCOPY | Cathartics - administration & dosage | Prospective Studies | Double-Blind Method | Phosphates - administration & dosage | Humans | Male | Colonoscopy - methods | Young Adult | Therapeutic Irrigation - methods | Adolescent | Placebos | Adult | Female | Aged | Simethicone - administration & dosage | Antifoaming Agents - administration & dosage | Preoperative Care - methods | Brief
结肠镜 | 肠道 | 满意度 | 质量 | 磷酸钠 | 瓦斯 | 能见度 | 检查 | Bowel preparation | Colonoscopy | Simethicone | MULTICENTER | EFFICACY | PROSPECTIVE TRIAL | RANDOMIZED-TRIAL | ORAL CONTRAST AGENT | VISIBILITY | COATED CELLULOSE | COLONIC LAVAGE | ELECTROLYTE LAVAGE SOLUTION | GASTROENTEROLOGY & HEPATOLOGY | CAPSULE ENDOSCOPY | Cathartics - administration & dosage | Prospective Studies | Double-Blind Method | Phosphates - administration & dosage | Humans | Male | Colonoscopy - methods | Young Adult | Therapeutic Irrigation - methods | Adolescent | Placebos | Adult | Female | Aged | Simethicone - administration & dosage | Antifoaming Agents - administration & dosage | Preoperative Care - methods | Brief
Journal Article
Gastroenterology, ISSN 0016-5085, 05/2018, Volume 154, Issue 6, pp. S-1098 - S-1099
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 9340316 - 8
Objectives. Nonalcoholic steatohepatitis (NASH) can progress to advanced fibrosis; the link between intestinal bacterial overgrowth and NASH has been proposed....
PATHOGENESIS | MEDICINE, RESEARCH & EXPERIMENTAL | METFORMIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | FATTY LIVER-DISEASE | OBESE | EPIDEMIOLOGY | rRNA 16S | Software development | Control methods | Laboratories | Alcohol | Biodiversity | Gene sequencing | Body mass index | Liver cancer | Hepatitis | Microorganisms | Microbiota | Regression models | Mathematical analysis | Intestine | Rodents | Feces | Digestive tract | Deoxyribonucleic acid--DNA | Hypertension | Obesity | Liver diseases | Nutrition | Ethanol | Digestive system | Diabetes mellitus | Regression analysis | Metabolism | Patients | Studies | Weight control | Hospitals | Body mass | Body size | Fibrosis | Relative abundance | Metformin | Volatile organic compounds--VOCs | Diabetes | DNA sequencing
PATHOGENESIS | MEDICINE, RESEARCH & EXPERIMENTAL | METFORMIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | FATTY LIVER-DISEASE | OBESE | EPIDEMIOLOGY | rRNA 16S | Software development | Control methods | Laboratories | Alcohol | Biodiversity | Gene sequencing | Body mass index | Liver cancer | Hepatitis | Microorganisms | Microbiota | Regression models | Mathematical analysis | Intestine | Rodents | Feces | Digestive tract | Deoxyribonucleic acid--DNA | Hypertension | Obesity | Liver diseases | Nutrition | Ethanol | Digestive system | Diabetes mellitus | Regression analysis | Metabolism | Patients | Studies | Weight control | Hospitals | Body mass | Body size | Fibrosis | Relative abundance | Metformin | Volatile organic compounds--VOCs | Diabetes | DNA sequencing
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 03/2002, Volume 97, Issue 3, pp. 535 - 541
Portal vein thrombosis (PVT) is an uncommon cause for presinusoidal portal hypertension. Although several predisposing conditions are known to exist in the...
HEPATOCELLULAR-CARCINOMA | VASCULAR COMPLICATIONS | FACTOR-V-LEIDEN | LIVER-TRANSPLANTATION | THROMBOPHILIC STATE | VENOUS THROMBOSIS | ENHANCED MR-ANGIOGRAPHY | GASTROENTEROLOGY & HEPATOLOGY | SURGICAL-TREATMENT | TUMOR THROMBI | CANCER-PATIENT | Radiography | Venous Thrombosis - diagnosis | Venous Thrombosis - therapy | Humans | Portal Vein - physiopathology | Venous Thrombosis - physiopathology | Portal Vein - diagnostic imaging | Portal Vein - surgery
HEPATOCELLULAR-CARCINOMA | VASCULAR COMPLICATIONS | FACTOR-V-LEIDEN | LIVER-TRANSPLANTATION | THROMBOPHILIC STATE | VENOUS THROMBOSIS | ENHANCED MR-ANGIOGRAPHY | GASTROENTEROLOGY & HEPATOLOGY | SURGICAL-TREATMENT | TUMOR THROMBI | CANCER-PATIENT | Radiography | Venous Thrombosis - diagnosis | Venous Thrombosis - therapy | Humans | Portal Vein - physiopathology | Venous Thrombosis - physiopathology | Portal Vein - diagnostic imaging | Portal Vein - surgery
Journal Article
BioMed Research International, ISSN 2314-6133, 2016, Volume 2016, pp. 7963972 - 6
Background. An increased prevalence of metabolic syndrome including nonalcoholic fatty liver disease (NAFLD) was reported in psoriasis. NAFLD can progress to...
TRANSIENT ELASTOGRAPHY | FIBROSIS | MEDICINE, RESEARCH & EXPERIMENTAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BIOPSY | INCREASED PREVALENCE | RISK | NONALCOHOLIC STEATOHEPATITIS | FIBROTEST | MONITORING PATIENTS | LONG-TERM METHOTREXATE | Psoriasis - diagnostic imaging | Metabolic Syndrome - diagnostic imaging | Prevalence | Humans | Middle Aged | Male | Metabolic Syndrome - metabolism | Psoriasis - complications | Liver Cirrhosis - epidemiology | Liver Cirrhosis - diagnostic imaging | Liver - diagnostic imaging | Non-alcoholic Fatty Liver Disease - classification | Liver Cirrhosis - metabolism | Psoriasis - metabolism | Adult | Female | Metabolic Syndrome - epidemiology | Non-alcoholic Fatty Liver Disease - diagnostic imaging | Liver Cirrhosis - complications | Liver - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Metabolic Syndrome - complications | Psoriasis - epidemiology | Non-alcoholic Fatty Liver Disease - epidemiology | Elasticity Imaging Techniques | Measurement | Liver diseases | Psoriasis | Methotrexate | Analysis | Liver | Obesity | Body mass index | Hyperglycemia | Insulin resistance | Liver cirrhosis | Bile
TRANSIENT ELASTOGRAPHY | FIBROSIS | MEDICINE, RESEARCH & EXPERIMENTAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BIOPSY | INCREASED PREVALENCE | RISK | NONALCOHOLIC STEATOHEPATITIS | FIBROTEST | MONITORING PATIENTS | LONG-TERM METHOTREXATE | Psoriasis - diagnostic imaging | Metabolic Syndrome - diagnostic imaging | Prevalence | Humans | Middle Aged | Male | Metabolic Syndrome - metabolism | Psoriasis - complications | Liver Cirrhosis - epidemiology | Liver Cirrhosis - diagnostic imaging | Liver - diagnostic imaging | Non-alcoholic Fatty Liver Disease - classification | Liver Cirrhosis - metabolism | Psoriasis - metabolism | Adult | Female | Metabolic Syndrome - epidemiology | Non-alcoholic Fatty Liver Disease - diagnostic imaging | Liver Cirrhosis - complications | Liver - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Metabolic Syndrome - complications | Psoriasis - epidemiology | Non-alcoholic Fatty Liver Disease - epidemiology | Elasticity Imaging Techniques | Measurement | Liver diseases | Psoriasis | Methotrexate | Analysis | Liver | Obesity | Body mass index | Hyperglycemia | Insulin resistance | Liver cirrhosis | Bile
Journal Article
BioMed Research International, ISSN 2314-6133, 2017, Volume 2017, pp. 4327385 - 8
Aims. Proximal renal tubular dysfunction (PRTD) is an infrequent complication after nucleotide analogue therapy. We evaluated the outcomes of PRTD and...
BIOMARKERS | MEDICINE, RESEARCH & EXPERIMENTAL | HYPOPHOSPHATEMIA | TENOFOVIR DISOPROXIL FUMARATE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GUIDELINES | ADEFOVIR DIPIVOXIL THERAPY | REVERSIBILITY | LONG-TERM ADEFOVIR | FANCONI-SYNDROME | HIV-INFECTED PATIENTS | NEPHROTOXICITY | Potassium - metabolism | Kidney Tubules, Proximal - pathology | Prospective Studies | Uric Acid - metabolism | Follow-Up Studies | Kidney Diseases - pathology | Humans | Middle Aged | Male | Substance Withdrawal Syndrome - pathology | Glomerular Filtration Rate - drug effects | Nucleotides - therapeutic use | Phosphates - metabolism | Hepatitis B, Chronic - drug therapy | Kidney Tubules, Proximal - metabolism | beta 2-Microglobulin - metabolism | Female | Aged | Longitudinal Studies | Kidney Diseases - metabolism | Antiviral agents | Development and progression | Dosage and administration | Research | Uric acid | Chemical properties | Acidosis | Drug therapy | Risk factors | Hepatitis B | Urine | Phosphates | Excretion | Renal function | Kidneys | Analogue | Reabsorption | Criteria | Patients | Nucleotide analogs | Glomerular filtration rate | Hepatitis | Acquired immune deficiency syndrome--AIDS | Womens health | Human immunodeficiency virus--HIV | Biomarkers | Bioindicators | Hepatitis B virus | Potassium | Kidney transplantation
BIOMARKERS | MEDICINE, RESEARCH & EXPERIMENTAL | HYPOPHOSPHATEMIA | TENOFOVIR DISOPROXIL FUMARATE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GUIDELINES | ADEFOVIR DIPIVOXIL THERAPY | REVERSIBILITY | LONG-TERM ADEFOVIR | FANCONI-SYNDROME | HIV-INFECTED PATIENTS | NEPHROTOXICITY | Potassium - metabolism | Kidney Tubules, Proximal - pathology | Prospective Studies | Uric Acid - metabolism | Follow-Up Studies | Kidney Diseases - pathology | Humans | Middle Aged | Male | Substance Withdrawal Syndrome - pathology | Glomerular Filtration Rate - drug effects | Nucleotides - therapeutic use | Phosphates - metabolism | Hepatitis B, Chronic - drug therapy | Kidney Tubules, Proximal - metabolism | beta 2-Microglobulin - metabolism | Female | Aged | Longitudinal Studies | Kidney Diseases - metabolism | Antiviral agents | Development and progression | Dosage and administration | Research | Uric acid | Chemical properties | Acidosis | Drug therapy | Risk factors | Hepatitis B | Urine | Phosphates | Excretion | Renal function | Kidneys | Analogue | Reabsorption | Criteria | Patients | Nucleotide analogs | Glomerular filtration rate | Hepatitis | Acquired immune deficiency syndrome--AIDS | Womens health | Human immunodeficiency virus--HIV | Biomarkers | Bioindicators | Hepatitis B virus | Potassium | Kidney transplantation
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 5362810 - 8
Hepatorenal syndrome (HRS) decreases survival of cirrhotic patients. The outcomes of HRS after liver transplantation (LT) were inconsistently reported. We...
Treatment Outcome | Liver Transplantation | Hepatorenal Syndrome - surgery | Humans | Middle Aged | Statistical analysis | Liver diseases | Kidneys | Transplants & implants | Liver | Mortality | Systematic review | Transplantation | Patients | Survival | Clinical outcomes | Graft rejection | Meta-analysis | Confidence intervals | Studies | Heterogeneity | Gastroenterology | Death | Liver transplantation
Treatment Outcome | Liver Transplantation | Hepatorenal Syndrome - surgery | Humans | Middle Aged | Statistical analysis | Liver diseases | Kidneys | Transplants & implants | Liver | Mortality | Systematic review | Transplantation | Patients | Survival | Clinical outcomes | Graft rejection | Meta-analysis | Confidence intervals | Studies | Heterogeneity | Gastroenterology | Death | Liver transplantation
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 10/2016, Volume 16, Issue 1, p. 135
Background: Toxic liver diseases are mainly caused by drug-induced liver injury (DILI). We assessed incidences and outcomes of DILI including associated...
Cirrhosis | Hepatitis | Anti-mycobacterial agents | Drug-induced liver injury | Acetaminophen | EVENTS | ADMINISTRATIVE DATA | HEALTH-CARE | IDENTIFICATION | KOREA | GASTROENTEROLOGY & HEPATOLOGY | FEATURES | Acetaminophen - adverse effects | Multivariate Analysis | Antitubercular Agents - adverse effects | Age Factors | Humans | Middle Aged | Thailand - epidemiology | Chemical and Drug Induced Liver Injury - mortality | Hospitalization - statistics & numerical data | Male | Fibrosis - mortality | Chemical and Drug Induced Liver Injury - economics | Incidence | Analgesics, Non-Narcotic - adverse effects | Adult | Female | Retrospective Studies | Databases, Factual | Fibrosis - chemically induced | Hospital Mortality | Risk Factors | Proportional Hazards Models | Chemical and Drug Induced Liver Injury - epidemiology | Chemical and Drug Induced Liver Injury - complications | Sex Factors | Aged | Drugs | Complications and side effects | Prognosis | Mortality | Causes of | Diagnosis | Research | Thailand | Liver cirrhosis | Health aspects
Cirrhosis | Hepatitis | Anti-mycobacterial agents | Drug-induced liver injury | Acetaminophen | EVENTS | ADMINISTRATIVE DATA | HEALTH-CARE | IDENTIFICATION | KOREA | GASTROENTEROLOGY & HEPATOLOGY | FEATURES | Acetaminophen - adverse effects | Multivariate Analysis | Antitubercular Agents - adverse effects | Age Factors | Humans | Middle Aged | Thailand - epidemiology | Chemical and Drug Induced Liver Injury - mortality | Hospitalization - statistics & numerical data | Male | Fibrosis - mortality | Chemical and Drug Induced Liver Injury - economics | Incidence | Analgesics, Non-Narcotic - adverse effects | Adult | Female | Retrospective Studies | Databases, Factual | Fibrosis - chemically induced | Hospital Mortality | Risk Factors | Proportional Hazards Models | Chemical and Drug Induced Liver Injury - epidemiology | Chemical and Drug Induced Liver Injury - complications | Sex Factors | Aged | Drugs | Complications and side effects | Prognosis | Mortality | Causes of | Diagnosis | Research | Thailand | Liver cirrhosis | Health aspects
Journal Article